|
Volumn 322, Issue 1-2, 2002, Pages 21-28
|
Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker
|
Author keywords
Cancer; Cell death; Folate; Oxidative stress; Risk factor; Tissue culture; Total serum homocysteine; Tumor marker
|
Indexed keywords
DNA;
FOLIC ACID;
FOLIC ACID ANTAGONIST;
HOMOCYSTEINE;
HOMOCYSTEINE THIOLACTONE;
TUMOR MARKER;
CANCER;
CANCER DIAGNOSIS;
CANCER PATIENT;
CANCER RISK;
CANCER THERAPY;
CARCINOGENESIS;
CARDIOVASCULAR RISK;
CELL DEATH;
CELL PROLIFERATION;
CIRCULATION;
CORRELATION ANALYSIS;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC VALUE;
DISEASE ASSOCIATION;
DNA METHYLATION;
FOLIC ACID DEFICIENCY;
HEMOCONCENTRATION;
HUMAN;
HYPERHOMOCYSTEINEMIA;
ISCHEMIC HEART DISEASE;
OXIDATIVE STRESS;
PATIENT MONITORING;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
PROTEIN DETERMINATION;
PROTEIN METABOLISM;
REVIEW;
RISK FACTOR;
TUMOR CELL CULTURE;
TUMOR GROWTH;
HOMOCYSTEINE;
HUMANS;
HYPERHOMOCYSTEINEMIA;
NEOPLASMS;
OXIDATIVE STRESS;
RISK FACTORS;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 0036294472
PISSN: 00098981
EISSN: None
Source Type: Journal
DOI: 10.1016/S0009-8981(02)00174-2 Document Type: Review |
Times cited : (188)
|
References (31)
|